Checked
Curative Biotechnology Inc
OTC: CUBT · Biological Products, (No Diagnostic Substances) · Boca Raton, FL
- Last filing
- 12/22/2025
- Filings on record
- 33
Company details
As reported to the SEC
- SEC CIK
- 1400271
- Stock
- OTC: CUBT
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) (2836)
- Headquarters
- 1825 NW Corporate Blvd, Suite 110, Boca Raton, FL 33431
- Incorporated in
- Florida
- Fiscal year end (SEC record)
- December 31
- Phone
- (800) 526-8006
- Employer ID (EIN)
- 72-1550658
Formerly: Connectyx Technologies Corp (until 10/13/2009)
No annual XBRL financial data in U.S. dollars is available for this company. Funds, very new registrants, and some foreign companies that report in other currencies do not have it. See the filings below or on EDGAR.
Recent filings
33 recent filings on record
Swipe the table sideways to see more columns.
| Form | Filed | Period |
|---|---|---|
| RWSEC filing | 12/22/2025 | None |
| S-1/ARegistration statement (amended) | 08/01/2025 | None |
| S-1Registration statement (new securities) | 05/06/2024 | None |
| RWSEC filing | 02/01/2024 | None |
| S-1/ARegistration statement (amended) | 01/25/2023 | None |
| DNotice of exempt offering (Form D) | 01/18/2023 | None |
| S-1/ARegistration statement (amended) | 01/13/2023 | None |
| S-1/ARegistration statement (amended) | 01/09/2023 | None |
| 8-A12B/ASEC filing | 12/01/2022 | None |
| S-1/ARegistration statement (amended) | 11/30/2022 | None |
| S-1/ARegistration statement (amended) | 11/16/2022 | None |
| S-1Registration statement (new securities) | 11/07/2022 | None |
| RWSEC filing | 10/31/2022 | None |
| EFFECTNotice of effectiveness | 10/13/2022 | None |
| CORRESPLetter to the SEC staff | 10/11/2022 | None |
| 8-A12BSEC filing | 10/05/2022 | None |
| CERTSEC filing | 10/05/2022 | None |
| CORRESPLetter to the SEC staff | 09/30/2022 | None |
| S-1/ARegistration statement (amended) | 09/30/2022 | None |
| UPLOADLetter from the SEC staff | 09/29/2022 | None |
Other biological products, (no diagnostic substances)
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Amgen IncAMGN | Thousand Oaks, CA | $36.75B | $7.71B |
| Gilead Sciences, Inc.GILD | Foster City, CA | $29.44B | $8.51B |
| Biogen Inc.BIIB | Cambridge, MA | $9.89B | $1.29B |
| Neurocrine Biosciences IncNBIX | San Diego, CA | $2.86B | $478.6M |
| Exelixis, Inc.EXEL | Alameda, CA | $2.32B | $782.6M |
| Qiagen N.V.QGEN | Pl Venlo, Netherlands | $2.09B | $424.9M |
| Moderna, Inc.MRNA | Cambridge, MA | $1.94B | -$2.82B |
| Halozyme Therapeutics, Inc.HALO | San Diego, CA | $1.4B | $316.9M |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Curative Biotechnology Inc's CIK number?
- Curative Biotechnology Inc's SEC Central Index Key (CIK) is 1400271.
- What is Curative Biotechnology Inc's stock ticker?
- Curative Biotechnology Inc trades as OTC: CUBT.
- When does Curative Biotechnology Inc's fiscal year end?
- Curative Biotechnology Inc's fiscal year end on file with the SEC is December 31.
- Where is Curative Biotechnology Inc headquartered?
- Curative Biotechnology Inc's principal executive office on file with the SEC is in Boca Raton, FL.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026